Endocrine-related cancer, 1351-0088

Journal

1 - 10 out of 23Page size: 10

Publications

  1. 2017
  2. Published

    Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF

    Imruetaicharoenchoke, W., Alice Fletcher, Wenqi Lu, Watkins, RJ., Modasia, B., Poole, V., Hannah Nieto, Thompson, R., Kristien Boelaert, Martin Read, Vicki Smith & Christopher McCabe, Sep 2017, In : Endocrine-related cancer. 24, 9, p. 459-474

    Research output: Contribution to journal › Article

  3. Published

    From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

    Asa, S. L. & Niki Karavitaki, 1 Apr 2017, In : Endocrine-related cancer. 24, p. C5-C8

    Research output: Contribution to journal › Article

  4. 2016
  5. Published

    Thyroid stimulating hormone in thyroid cancer: does it matter?

    Hannah Nieto & Kristien Boelaert, 1 Nov 2016, In : Endocrine-related cancer. 23, 11, ERC-16-0328.

    Research output: Contribution to journal › Article

  6. Published

    WOMEN IN CANCER PROFILE: From bedside to bench and back: my journey in thyroid disease

    Kristien Boelaert, Nov 2016, In : Endocrine-related cancer. 23, 11, p. 9-13

    Research output: Contribution to journal › Special issue

  7. E-pub ahead of print

    In Touch with your Feminine Side: How Oestrogen Metabolism Impacts Prostate Cancer

    Rahman, H-U., Hofland, J. & Paul Foster, 18 May 2016, In : Endocrine-related cancer.

    Research output: Contribution to journal › Article

  8. 2015
  9. Published

    The 8q24 rs6983267G variant is associated with increased thyroid cancer risk

    Sahasrabudhe, R., Carvajal-Carmona, LG., TCUKIN Consortium & Colorectal Tumour Gene Identification (CORGI) Consortium, Oct 2015, Endocrine-related cancer, 22, 5, p. 841-849.

    Research output: Contribution to specialist publication › Article

  10. 2013
  11. Published

    Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy

    Hvid, T., Winding, K., Rinnov, A., Dejgaard, T., Thomsen, C., Iversen, P., Brasso, K., Mikines, K. J., van Hall, G., Lindegaard, B., Thomas Solomon & Pedersen, B. K., Oct 2013, In : Endocrine-related cancer. 20, 5, p. 621-32 12 p.

    Research output: Contribution to journal › Article

  12. Published

    The management of head-and-neck paragangliomas

    Capatina, C., Ntali, G., Niki Karavitaki & Grossman, A. B., Oct 2013, In : Endocrine-related cancer. 20, 5, p. R291-305

    Research output: Contribution to journal › Article

  13. Published

    STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model

    Day, J. M., Paul Foster, Tutill, H. J., Schmidlin, F., Sharland, C. M., Hargrave, J. D., Vicker, N., Potter, B. V. L., Reed, M. J. & Purohit, A., 2013, In : Endocrine-related cancer. 20, 1, p. 53-64 12 p.

    Research output: Contribution to journal › Article

  14. 2012
  15. Published

    Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide

    Thompson, I. R., Chand, A. N., King, P. J., Ansorge, O., Niki Karavitaki, Jones, C. A., Rahmutula, D., Gardner, D. G., Zivkovic, V., Wheeler-Jones, C. P., McGonnell, I. M., Korbonits, M., Anderson, R. A., Wass, J. A. H., McNeilly, A. S. & Fowkes, R. C., Aug 2012, In : Endocrine-related cancer. 19, 4, p. 497-508 12 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next